Obesity-Linked Gaps in Pulmonary Embolism Management – Shared by Zain Khalpey
Zain Khalpey, Chief Medical AI Officer, Chair of Applied Clinical AI, Director, Khalpey AI Lab at ATARI AI, posted on LinkedIn:
”Obesity changes everything about pulmonary embolism from diagnosis to drug dosing.
This new JACC review highlights how body size complicates imaging accuracy, influences anticoagulant and interventional choices, and even shapes outcomes through the “obesity paradox.”
The takeaway is clear: one size fits all guidance doesn’t work.
We need pragmatic, obesity-aware protocols and updated guidelines that reflect real world patients.
Full review here.
Follow Zain Khalpey for more on AI and Healthcare.”
Title: Obesity and Acute Pulmonary Embolism: Clinical Implications and Knowledge Gaps
Authors: Marco Zuin, Gregory Piazza, Stefano Barco, Laurent Bertoletti, Michal Ciurzynski, Nika Skoro-Sajer, Marcin Kurzyna, Sophia Anastasia Mouratoglou, Lukas Hobohm, Frederikus A. Klok
Keep up with Hemostasis Today.
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
-
Jan 7, 2026, 05:04Heghine Khachatryan on VWD: A Landmark in the History of Hematology
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications